Journal
ANALYTICAL LETTERS
Volume 41, Issue 4, Pages 561-570Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/00032710801910742
Keywords
tenofovir; human plasma; RP-HPLC
Categories
Ask authors/readers for more resources
A simple reverse-phase high-performance liquid chromatographic method for the determination of tenofovir disoproxil fumarate (TDF) in pharmaceutical formulations and human plasma samples has been developed and validated. Piroxicam (PRX) was used as an internal standard. The assay of the drug was performed on a CLC C-18 (5 mu, 25 cm x 4.6 mm i.d.) with UV detection at 259 nm. The mobile phase consisted of acetonitrile - water mixture in the ratio of 75: 25, and a flow rate of 1 ml/min was maintained. The standard curve was linear over the range of 0.2 - 10 mu g/ml (r(2) = 0.9966). Analytic parameters have been evaluated. Within-day and between-day precision as expressed by relative standard deviation was found to be less than 2%. The method has been applied successfully for the determination of TDF in spiked human plasma samples and pharmaceutical formulations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available